Apoptosis-Inducing Anticancer Drugs in Clinical Trials
Author:
Hu Wei,Kavanagh John J.
Publisher
Springer-Verlag
Reference112 articles.
1. M. Jaattela. Programmed cell death: many ways for cells to die decently. Ann Med, 34: 480–488 (2002).
2. J. C. Reed. Apoptosis-based therapies. Nat Rev Drug Discov, 1: 111–121 (2002).
3. S. J. Korsmeyer, Wei M. C., Saito M., Weiler S., Oh K. J., and Schlesinger P. H. Proapoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ, 7: 1166–1173 (2000).
4. X. M. Sun, MacFarlane M., Zhuang J., Wolf B. B., Green D. R., and Cohen G. M. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem, 274: 5053–5060 (1999).
5. Y. L. Yang and Li X. M. The IAP family: endogenous caspase inhibitors with multiple biological activities. Cell Res, 10: 169–177 (2000).